hepatitis b immune globulin (human) (BayHep B) Report issue

Biological Approved FDA
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

$57.3200 - $103.0700
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

anti-hepatitis b immunoglobulin | bayhep b | biguanide | bioguanide | bt088 immunoglobulin, human | hbig | h-big | hepabulin | hepagam b | hepatitis b hyperimmune globulin | hepatitis b immune globulin | hepatitis b immune globulin (human) | hepatitis b immunoglobulin | hepatitis b virus immune globulin | hep-b-gammagee | human hepatitis b immunoglobulin | human hepatitis-b immunoglobulin | human hepatitis b virus immune globulin | liberim hb | zutectra

Organizations (74)

Research & Development (74)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (1)


 

Hepatitis B Antibodies (approved 1977)

Experimental Indications - Clinical Trial Phases 1-4 (10)


 

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Healthy Volunteers (Phase 1)

Heart Diseases (Phase 3)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 3)

Insulin Resistance (Phase 3)

Liver Transplantation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 34
  • # of Trial Organizations: 74

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue